Cancer Vaccines

Scientists Say New Vaccine Doubles Survival Rates in Mice

Published in Vaccine Weekly, September 25th, 1995

Researchers have developed a vaccine that more than doubled the survival rates for cancer-ridden mice, said scientists at the U.S. National Cancer Institute's (NCI) Frederick campus at Fort Detrick.

Previous vaccines required part of the patient's own tumor. A vaccine made from a generalized tumor would be easier and less expensive to produce, said Dr. Ronald Hornung, an author of the study published in the Journal of the National Cancer Institute.

Studies show such vaccines help fight slow-growing cancers resistant to chemotherapy or other treatments.

In this study, mice with cancerous tumors received bone-marrow transplants...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1995-09-25)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry